Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
This study has been withdrawn prior to enrollment.
Eastern Cooperative Oncology Group
Information provided by:
National Cancer Institute (NCI)
First received: September 26, 2005
Last updated: October 24, 2006
Last verified: October 2006
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||No date given|